[Use of hematopoietic growth factors in nonmalignant neutropenias in adults].
The results of clinical trials suggest that human hematopoietic factors are very usefull in overcoming neutropenia. Particularly, the great clinical benefit after G-CSF, GM-CSF therapy is observed in different types of neutropenia (cyclic, chronic neutropenia) aplastic anaemia, and neutropenias in infection diseases. At present, in acquired immunodeficiency syndrome, GM-CSF and other CSFs are envisioned in a primarily adjunctive role, supporting blood counts during period of myelosuppressive drug therapy.
Konopka
L
L
Klinika Chorób Wewnetrznych, Instytut Hematologii i Transfuzjologii w Warszawie.
D000328:Adult; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use*; D006801:Humans; D009503:Neutropenia / Q000209:etiology / Q000628:therapy*
D016298:Hematopoietic Cell Growth Factors
Zastosowanie czynników wzrostu w nienowotworowych neutropeniach u dorosłych.